You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
534 Responses to immunotherapy based on programmed death-ligand 1 (PD-L1) copy number variation (CNV) status in patients with advanced non-small cell lung cancer (NSCLC)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023184014
Dec 20234505
Jan 20242003
Feb 20244201
Mar 20241800
Apr 20244001
May 20242401
Jun 20241402
Jul 20241200
Aug 20241000
Sep 20242000
Oct 20242206
Nov 20244603
Dec 2024202
Jan 20251604
Feb 2025402
Mar 2025001
Apr 2025001
May 2025003
Jun 2025002
Total519051